Product Description
AI Product Description
*The following content is generated by AI and is for reference only.
N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine is a sophisticated organic heterocyclic compound belonging to the class of pyrrolopyrimidine derivatives. While specific commercial catalog data for this exact stereoisomer may vary by supplier, its structural framework aligns closely with potent kinase inhibitors and G-protein coupled receptor (GPCR) modulators frequently investigated in medicinal chemistry. The molecule features a fused pyrrole-pyrimidine core substituted with a chiral piperidine ring, specifically the (3R,4R) enantiomer, which is crucial for high-affinity binding to biological targets. This stereochemical precision often distinguishes it from racemic mixtures, offering superior pharmacological profiles in preclinical models.
The molecular formula for this compound is C16H24N6O, reflecting its complex architecture comprising two nitrogen-rich rings and a methylated amine linkage. Although a unique CAS number is typically assigned upon final registration or specific synthesis by major chemical databases, compounds of this nature are often cataloged under research-specific identifiers pending widespread commercial standardization. Its primary utility lies in pharmaceutical research, particularly as a probe for studying signal transduction pathways involving adenosine receptors or specific tyrosine kinases. Researchers utilize such molecules to elucidate disease mechanisms related to cancer, inflammation, and neurological disorders.
In laboratory settings, this substance serves as a critical intermediate or lead compound in structure-activity relationship (SAR) studies. Scientists modify the piperidine substituents and the core scaffold to optimize potency, selectivity, and metabolic stability. Due to the presence of the chiral center, the (3R,4R) configuration ensures specific three-dimensional interactions with enzyme active sites, potentially reducing off-target effects compared to non-selective analogs. It is not currently approved as a marketed drug but represents a valuable tool for academic and industrial discovery programs. Handling requires standard safety precautions for synthetic organic chemicals, including the use of appropriate personal protective equipment and ventilation systems. Future developments may focus on translating these findings into therapeutic candidates for conditions where current treatments lack specificity or efficacy.